II
BSX icon

IFM Investors’s Boston Scientific BSX Stock Holding History

IFM Investors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6M Buy
366,521
+34,182
+10% +$1.86M 0.1% 177
2026
Q1 		$20.9M Buy
332,339
+8,151
+3% +$652K 0.17% 107
2025
Q4 		$30.9M Buy
324,188
+14,062
+5% +$1.38M 0.26% 75
2025
Q3 		$30.4M Buy
310,126
+6,109
+2% +$633K 0.27% 68
2025
Q2 		$32.7M Buy
304,017
+19,673
+7% +$1.99M 0.31% 59
2025
Q1 		$28.7M Sell
284,344
-221
-0.1% -$22.3K 0.31% 62
2024
Q4 		$25.4M Sell
284,565
-24,762
-8% -$2.18M 0.26% 70
2024
Q3 		$25.9M Buy
309,327
+1,597
+0.5% +$126K 0.25% 75
2024
Q2 		$23.7M Buy
307,730
+3,627
+1% +$265K 0.24% 82
2024
Q1 		$20.8M Sell
304,103
-5,247
-2% -$337K 0.23% 86
2023
Q4 		$17.9M Buy
309,350
+14,729
+5% +$786K 0.22% 94
2023
Q3 		$15.6M Buy
294,621
+8,564
+3% +$449K 0.2% 96
2023
Q2 		$15.5M Buy
286,057
+20,169
+8% +$1.05M 0.2% 96
2023
Q1 		$13.3M Buy
265,888
+6,495
+3% +$306K 0.2% 101
2022
Q4 		$12M Buy
259,393
+4,945
+2% +$214K 0.2% 107
2022
Q3 		$9.86M Buy
254,448
+3,730
+1% +$150K 0.18% 117
2022
Q2 		$9.34M Buy
250,718
+9,289
+4% +$378K 0.16% 129
2022
Q1 		$10.7M Buy
241,429
+43,729
+22% +$1.9M 0.17% 120
2021
Q4 		$8.4M Buy
197,700
+4,800
+2% +$202K 0.15% 130
2021
Q3 		$8.37M Buy
192,900
+3,032
+2% +$134K 0.17% 113
2021
Q2 		$8.12M Buy
189,868
+28,829
+18% +$1.21M 0.17% 128
2021
Q1 		$6.22M Buy
161,039
+22,111
+16% +$837K 0.17% 125
2020
Q4 		$4.99M Buy
138,928
+21,268
+18% +$767K 0.16% 131
2020
Q3 		$4.5M Buy
117,660
+14,456
+14% +$557K 0.19% 112
2020
Q2 		$3.62M Sell
103,204
-34,915
-25% -$1.26M 0.19% 116
2020
Q1 		$4.37M Sell
138,119
-5,065
-4% -$198K 0.2% 114
2019
Q4 		$6.47M Sell
143,184
-6,783
-5% -$284K 0.23% 94
2019
Q3 		$6.1M Buy
149,967
+53,258
+55% +$2.26M 0.23% 95
2019
Q2 		$4.16M Buy
96,709
+6,704
+7% +$258K 0.24% 89
2019
Q1 		$3.45M Buy
90,005
+10,276
+13% +$392K 0.22% 96
2018
Q4 		$2.82M Buy
79,729
+7,165
+10% +$260K 0.23% 95
2018
Q3 		$2.79M Buy
72,564
+10,259
+16% +$358K 0.21% 105
2018
Q2 		$2.04M Buy
62,305
+18,918
+44% +$571K 0.19% 115
2018
Q1 		$1.19M Buy
43,387
+4,149
+11% +$113K 0.17% 142
2017
Q4 		$973K Buy
39,238
+147
+0.4% +$4.05K 0.15% 154
2017
Q3 		$1.14M Buy
39,091
+2,038
+6% +$56.3K 0.19% 121
2017
Q2 		$1.03M Buy
37,053
+9,538
+35% +$253K 0.18% 129
2017
Q1 		$684K Buy
27,515
+10,410
+61% +$253K 0.17% 139
2016
Q4 		$370K Buy
+17,105
New +$373K 0.17% 153

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

IFM Investors's BSX Position: Q2 2026 in Review

IFM Investors increased its Boston Scientific (BSX) stake by 10% in Q2 2026, buying an estimated $1.86M and bringing the position to 366,521 shares worth $15.6M. The position accounts for 0.1% of the portfolio, ranked #177.

IFM Investors first reported a position in BSX in Q4 2016 and has held it in 39 quarters since. The position peaked at $32.7M in Q2 2025. 314 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • IFM Investors held 366,521 shares of Boston Scientific worth $15.6M as of Q2 2026.
  • IFM Investors bought 34,182 Boston Scientific shares in Q2 2026, an estimated $1.86M.
  • Boston Scientific made up 0.1% of IFM Investors's portfolio in Q2 2026, its #177 holding.
  • IFM Investors first reported a position in Boston Scientific in Q4 2016 and has held it in 39 quarters since.
  • IFM Investors's Boston Scientific position peaked at $32.7M in Q2 2025.
  • 314 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.